Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02664909 · ClinicalTrials.gov registry record · Phase 4
Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty
A Phase 4 study, sponsored by UConn Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
NCT02664909 is a Phase 4 study that has completed, run by UConn Health. The registered enrollment target is 36 participants.
The verdict
NCT02664909, a Phase 4 study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
Study Summary
This study is a double-blinded placebo-controlled clinical trial evaluating the efficacy of 1 gram of topically applied tranexamic acid vs. saline placebo for the reduction of transfusion following hip hemiarthroplasty surgery.
Interventions
- DRUG Tranexamic Acid
- DRUG Placebo (saline)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2016-01-01 |
| Est. Completion | 2019-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02664909
The ClinicalTrials.gov registry entry for NCT02664909 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tranexamic Acid is the first listed.
NCT02664909 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02664909 about?
NCT02664909 is a clinical study titled "Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty". This study is a double-blinded placebo-controlled clinical trial evaluating the efficacy of 1 gram of topically applied tranexamic acid vs. saline placebo for the reduction of transfusion following hip hemiarthroplasty surgery.
What is the current status of trial NCT02664909?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2016-01-01. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT02664909?
The interventions under investigation include: Tranexamic Acid (DRUG), Placebo (saline) (DRUG).
Who is sponsoring clinical trial NCT02664909?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.